Report Feature
The future of the global stem cell biotechnology market looks promising with opportunities in therapeutic applications, such as musculoskeletal disorders, wounds and injuries, cardiovascular diseases, surgeries, and gastrointestinal diseases. The global stem cell biotechnology market is expected to grow with a CAGR of 10%-12% from 2020 to 2025. The major drivers for this market are increasing awareness of the therapeutic potency of stem cells in effective disease management and increasing public and private investments for the development of stem cell therapies.
A total of XX figures / charts and XX tables are provided in this more than 150-page report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global stem cell biotechnology market report, please download the report brochure.
In this market, adipose tissue-derived mesenchymal ste, cell is the largest cell source of stem cell biotechnology, whereas musculoskeletal disorder is the largest application. Growth in various segments of the stem cell biotechnology market are given below:
The study includes trends and forecast for the global stem cell biotechnology market by type, cell source, therapeutic application, and region as follows:
By Type [Value ($ Million) shipment analysis for 2014 – 2025]:
- Allogeneic Stem Cell Therapy
- Autologous Stem Cell Therapy
By Cell Source [Value ($ Million) shipment analysis for 2014 – 2025]:
- Adipose Tissue-Derived Mesenchymal Stem Cells
- Bone Marrow-Derived Mesenchymal Stem Cells
- Cord Blood/Embryonic Stem Cells
- Other Cell Sources
By Therapeutic Application [Value ($ Million) shipment analysis for 2014 – 2025]:
- Musculoskeletal Disorders
- Wounds and Injuries
- Cardiovascular Diseases
- Surgeries
- Gastrointestinal Diseases
- Other Applications
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
-
North America
- United States
- Canada
- Mexico
-
Europe
- United Kingdom
- Germany
- France
-
Asia Pacific
- China
- India
- Japan
-
The Rest of the World
- Brazil
Some of the stem cell biotechnology companies profiled in this report include Osiris Therapeutics, MEDIPOST, Anterogen, Pharmicell, Holostem Terapie Avanzate, JCR Pharmaceuticals, NuVasive, RTI Surgical, AlloSource, and Athersys.
Lucintel forecasts that adipose tissue-derived mesenchymal stem cells will remain the largest cell source segment over the forecast period due to a large number of therapeutic applications offered by adipose tissue-derived stem cells and increasing demand for easy and accessible stem cell sources.
Within this market, musculoskeletal disorders will remain the largest therapeutic application segment over the forecast period due to rising prevalence of musculoskeletal disorders and the availability of a larger number of stem cell therapy products for the treatment of musculoskeletal disorders.
North America will remain the largest region over the forecast period due to the adoption of treatment at an early stage and increasing awareness among people.
|
Features of the Global Stem Cell Biotechnology Market |
|
|
This report answers following key questions |
|
Q.1 What are some of the most promising potential, high-growth opportunities for the global stem cell biotechnology market by type (allogeneic stem cell therapy and autologous stem cell therapy), cell source (adipose tissue-derived mesenchymal stem cells, bone marrow-derived mesenchymal stem cells, cord blood/embryonic stem cells, and other cell sources), therapeutic application (musculoskeletal disorders, wounds and injuries, cardiovascular diseases, surgeries, gastrointestinal diseases, and other applications), and region (North America, Europe, Asia Pacific, and Rest of the World)? Q.2 Which segments will grow at a faster pace and why? Q.3 Which region will grow at a faster pace and why? Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global stem cell biotechnology market? Q.5 What are the business risks and threats to the global stem cell biotechnology market? Q.6 What are the emerging trends in this stem cell biotechnology market and the reasons behind them? Q.7 What are some changing demands of customers in the stem cell biotechnology market? Q.8 What are the new developments in this stem cell biotechnology market? Which companies are leading these developments? Q.9 Who are the major players in the stem cell biotechnology market? What strategic initiatives are being implemented by key players for business growth? Q.10 What are some of the competitive products and processes in the stem cell biotechnology market, and how big of a threat do they pose for loss of market share via material or product substitution? Q.11 What M&A activities did take place in the last five years in the global stem cell biotechnology market? |
Report Scope
| Key Features | Description |
| Base Year for Estimation | 2019 |
|
Trend Period (Actual Estimates) |
2014-2019 |
| Forecast Period | 2020-2025 |
| Pages | More than 150 |
| Market Representation / Units | Revenue in US $ Million |
| Report Coverage | Market Trends & Forecast, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions, & Joint Venture, and Company Profiling |
| Market Segments | Type (Allogeneic Stem Cell Therapy and Autologous Stem Cell Therapy), Cell Source (Adipose Tissue-Derived Mesenchymal Stem Cells, Bone Marrow-Derived Mesenchymal Stem Cells, Cord Blood/Embryonic Stem Cells, and Other Cell Sources), and Therapeutic Application (Musculoskeletal Disorders, Wounds and Injuries, Cardiovascular Diseases, Surgeries, Gastrointestinal Diseases, and Other Applications) |
Regional Scope |
North America (USA, Mexico, and Canada), Europe (United Kingdom, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil) |
| Customization | 10% Customization without Any Additional Cost |
Table of Contents
1. Executive Summary
7.2 Emerging Trends in the Global Stem Cell Biotechnology Market
4.1 Global Stem Cell Biotechnology Market by Region
4.2.1 Market by Type: Allogeneic Stem Cell Therapy and Autologous Stem Cell Therapy
4.2.2 Market by Cell Source: Adipose Tissue-Derived Mesenchymal Stem Cells, Bone Marrow-Derived Mesenchymal Stem Cells, Cord Blood/Embryonic Stem Cells, and Other Cell Sources
4.2.3 Market by Therapeutic Application: Musculoskeletal Disorders, Wounds and Injuries, Cardiovascular Diseases, Surgeries, Gastrointestinal Diseases, and Other Applications
4.2.4 The United States Stem Cell Biotechnology Market
4.2.5 The Canadian Stem Cell Biotechnology Market
4.2.6 The Mexican Stem Cell Biotechnology Market
4.3.1 Market by Type: Allogeneic Stem Cell Therapy and Autologous Stem Cell Therapy
4.3.2 Market by Cell Source: Adipose Tissue-Derived Mesenchymal Stem Cells, Bone Marrow-Derived Mesenchymal Stem Cells, Cord Blood/Embryonic Stem Cells, and Other Cell Sources
4.3.3 Market by Therapeutic Application: Musculoskeletal Disorders, Wounds and Injuries, Cardiovascular Diseases, Surgeries, Gastrointestinal Diseases, and Other Applications
4.3.4 The Stem Cell Biotechnology Market of the United Kingdom
4.3.5 The German Stem Cell Biotechnology Market
4.3.6 The French Stem Cell Biotechnology Market
4.4.1 Market by Type: Allogeneic Stem Cell Therapy and Autologous Stem Cell Therapy
4.4.2 Market by Cell Source: Adipose Tissue-Derived Mesenchymal Stem Cells, Bone Marrow-Derived Mesenchymal Stem Cells, Cord Blood/Embryonic Stem Cells, and Other Cell Sources
4.4.3 Market by Therapeutic Application: Musculoskeletal Disorders, Wounds and Injuries, Cardiovascular Diseases, Surgeries, Gastrointestinal Diseases, and Other Applications
4.4.4 The Chinese Stem Cell Biotechnology Market
4.4.5 The Indian Stem Cell Biotechnology Market
4.4.6 The Japanese Stem Cell Biotechnology Market
4.5.1 Market by Type: Allogeneic Stem Cell Therapy and Autologous Stem Cell Therapy
4.5.2 Market by Cell Source: Adipose Tissue-Derived Mesenchymal Stem Cells, Bone Marrow-Derived Mesenchymal Stem Cells, Cord Blood/Embryonic Stem Cells, and Other Cell Sources
4.5.3 Market by Therapeutic Application: Musculoskeletal Disorders, Wounds and Injuries, Cardiovascular Diseases, Surgeries, Gastrointestinal Diseases, and Other Applications
4.5.4 Brazilian Stem Cell Biotechnology Market
7.1.1 Growth Opportunities for the Global Stem Cell Biotechnology Market by Type
7.1.2 Growth Opportunities for the Global Stem Cell Biotechnology Market by Cell Source
7.1.3 Growth Opportunities for the Global Stem Cell Biotechnology Market by Therapeutic Application
7.1.4 Growth Opportunities for the Global Stem Cell Biotechnology Market by Region
Methodology
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
- In-depth interviews of the major players in this market
- Detailed secondary research from competitors’ financial statements and published data
- Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
- A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Buy Now
Choose a license that fits your team. Instant PDF delivery.
Prices exclude taxes. Instant delivery. Custom licensing available on request.
